Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium as Intracanal Medicament in Chronic Apical Periodontitis
NCT06207253Phase 3Recruiting
- Sponsor
- The British University in Egypt
- Start
- Nov 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac in apical periodontitis (AP), sponsored by The British University in Egypt. Started Nov 2025; status: recruiting.
02
Drugs
diclofenac
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT06207253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06207253.